Novartis Investigative Site

Rio de Janiero, Rio de Janeiro 20231-050

0 studies enrolling now · 3 studies all time

What they study most

Chronic Myeloid Leukemia, Differentiated Thyroid Cancer (DTC), Relapsing Forms of Multiple Sclerosis

Studies at this site

• Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer — Running, not enrolling
• Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) — Completed
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed